| Julianne E Rictor, LP00057089 | |
|
420 S 32nd Ave, Yakima, WA 98902-3635 | |
| (509) 823-4200 | |
| (509) 823-4220 |
| Full Name | Julianne E Rictor |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 420 S 32nd Ave, Yakima, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538684642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LP00057089 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julianne E Rictor, LP00057089 420 S 32nd Ave, Yakima, WA 98902-3635 Ph: (509) 823-4200 | Julianne E Rictor, LP00057089 420 S 32nd Ave, Yakima, WA 98902-3635 Ph: (509) 823-4200 |
News Archive
Citing the hardships certain to be faced by a population of California cancer patients on strained incomes, the National Patient Advocate Foundation (NPAF), a national non-profit organization providing the patient voice for legislative reform at the state and federal levels, pulled its support for AB 219 following amendments passed in the California state senate yesterday that would prohibitively increase the co-pay for oral cancer treatment.
A new study by researchers at the Oregon Health & Science University (OHSU) in the USA goes far in answering this question by showing the presence of memory B cells that react to the original SARS-CoV-2 as well as VOCs.
Giving children under 5 years old an extra dose of inactivated polio vaccine (IPV) helps to boost their immunity to the poliovirus and should be added to vaccination programmes in polio-endemic countries and those facing a high risk of imported cases, suggests new research published in The Lancet.
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 –30 in Athens, Greece.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its Mobi-C® Cervical Disc (Mobi-C). Mobi-C is a metal and polyethylene mobile bearing prosthesis specifically designed as a low-profile cervical intervertebral disc replacement for both one and two level applications.
› Verified 4 days ago
Christie A Waddington, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 402 S 4th Ave, Yakima, WA 98902 Phone: 509-575-4084 | |
Shannon R Guthrie, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 402 S 4th Ave, Yakima, WA 98902 Phone: 509-575-4084 | |
Mrs. Susan Schell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6513 W.chestnut Ave, Elite Nursing, Yakima, WA 98908 Phone: 509-388-4750 | |
Jane Hickman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 402 S 4th Ave, Yakima, WA 98902 Phone: 509-575-4084 | |
Angie Alvarez, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 S 2nd Ave, Yakima, WA 98902 Phone: 509-575-4084 | |
Joy A Gere, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 402 S 4th Ave, Yakima, WA 98902 Phone: 509-575-4084 | |
Esmeralda Macias, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 E Nob Hill Blvd, Yakima, WA 98901 Phone: 509-457-6540 |